Category Archives: Gesundheit/Medizin

Gesundheit/Medizin Pressemitteilungen

Hemodialysis Access Graft Market Analysis 2018-2026

Hemodialysis is one among the three renal replacement therapies used for extracorporeal separation of waste components from the blood in case of kidney failure. Hemodialysis access, also known as vascular access, is a way to access blood for hemodialysis, which can be obtained by three different ways, a fistula, a graft, and a catheter. Hemodialysis access graft are the U-shaped plastic tube used for hemodialysis, which join an artery and veins under the skin of the patient’ arms. Hemodialysis access graft are used in patients with blocked or damaged veins, in which fistula cannot be used. However, hemodialysis access graft do not last as long as fistula, which is expected to be the major factor restraining the hemodialysis access graft market growth.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1840

Hemodialysis Access Graft Market Dynamics

Novel product launches by market players is a major factor expected to fuel growth the hemodialysis access graft market over the forecast period. For instance, in 2013, CryoLife, Inc., received CE mark for the HeRO Graft, for patients with failing fistulas or blocked veins leading to heart. The company claims HeRO graft as the only fully subcutaneous AV access solution. In 2013, Gore & Associates, launched Gore Acuseal vascular graft for vascular access. The key feature of Gore Acuseal vascular graft is it provides early cannulation i.e. within 24 hours of post-implantation, owing to its trilayer design with low-bleed elastomeric membrane sandwiched between two expanded polytetrafluoroethylene layers. Various companies are adopting trilayer design to sustain in the hemodialysis access graft market. Thus, this can be a growth opportunity for emerging and new entrants in the market.

Hemodialysis Access Graft Market – Regional Analysis

Regional segmentation of hemodialysis access graft market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America hemodialysis access graft market is expected to hold a dominant position over the forecast period. This is owing to high prevalence of kidney failure in the region. For instance, according to National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), 2015, in America, around 661,000 Americans suffer from kidney failure, of which 468,000 individuals are on dialysis.

Hemodialysis Access Graft Market – Competitive Analysis

Key players operating in the global hemodialysis access graft market are W.L. Gore & Associated, C. R. Bard, Merit Medical Systems, Inc. and Getinge Group.

Request for TOC : https://www.coherentmarketinsights.com/ongoing-insight/toc/1840

Hemodialysis Access Graft Market Taxonomy

Based on material:

  • Biological Grafts
  • Synthetic Grafts
  • Biosynthetic Grafts

Based on end user:

  • Hospitals
  • Dialysis centers
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings

Based on region:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East
  • Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Gesundheit/Medizin Pressemitteilungen

Linear Accelerators for Radiation Market outlook 2026

A linear accelerator is commonly used in external beam radiation treatments, for patients with cancer. Linear accelerator customizes high energy x-rays or electrons depending on a tumor’s shape and destroys cancer cells while sparing surrounding normal tissue. It is designed with build-up safety features to ensure that it will not deliver a higher dose than prescribed. The linear accelerator is used to treat all parts or organs of the body, by delivering high-energy x-rays or electrons to the region of the patient’s tumor. A radiation oncologist prescribes the appropriate treatment volume and dosage of radiation.
Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1855

Linear Accelerators for Radiation Market Drivers

Increasing number of initiatives by various government and private organizations in early diagnosis of cancer, increases the survival rate, and reduces cancer mortality rate, and this is expected to help to boost market growth of linear accelerators for radiation. For instance, in February 2017, World Health Organization (WHO) proposed new guidelines to improve survival rate of people living with cancer, by ensuring that health service providers can focus on diagnosing and treating the disease earlier. WHO proposed three steps to early diagnosis are: improve public awareness of different cancer symptoms, invest in strengthening and equipping health services and training and ensuring people living with cancer can access safe and effective treatment. Moreover, Cancer Research UK organized Early Diagnosis Research Conference in February 2017, to share and discuss latest developments in early diagnosis research.

Growth of the linear accelerators for radiation market size is driven by increasing prevalence and incidence of various types of cancer, along with growing patient awareness programs by government and private organizations, and rising adoption of radiotherapy in cancer treatment. For instance, according to the Cancer Atlas: 2017, there were an estimated 14.1 million new cancer cases in 2012. Moreover, India, China, and other East and Central Asian countries accounted for nearly half of world’s new cancer cases and deaths, in 2017. Furthermore, according to the same source, by 2025, there will be an estimated 19.3 million new cancer cases and 11.4 million cancer deaths, in less developed regions.

Request for TOChttps://www.coherentmarketinsights.com/ongoing-insight/toc/1855

Linear Accelerators for Radiation Market Restraints

Major concerns of affordability and accessibility for the treatment, lack of trained personnel to operate linear accelerators, are some of the limiting factors, which may hinder the future market growth for linear accelerators for radiation.

Linear Accelerators for Radiation Market – Regional Analysis

Geographically, global linear accelerators for radiation market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. Growing adoption of linear accelerators by prominent cancer treatment centers, worldwide; and upgrading the conventional treatment, will augment growth of the linear accelerators for radiation market, in the near future. In May 2016, Leeds Cancer Centre, a leading providers of cancer care in the U.K. updated its existing treatment equipment with eight Elekta Versa HD linear accelerators. The Versa HD linear accelerators combined with Volumetric Arc Therapy (VMAT) allows to deliver complex head and neck cancer therapy up to 42% faster. Furthermore, in November 2017, Romanian government signed for five Elekta linear accelerators, to supply the country with sophisticated radiation therapy devices. In addition, Princess Margaret Cancer Centre from Canada and Odense University Hospital from Denmark in December 2016, also ordered high-field MR-supported linear accelerator (MR-linac). Both Versa HD linear accelerator and high-field MR-supported linear accelerator (MR-linac) are manufactured by Elekta AB.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

 

Gesundheit/Medizin Pressemitteilungen

Biomedical Sealant Market Analysis 2026

Biomedical sealants have emerged as a promising product for replacing staples and sutures to prevent liquid and air leakages after and during surgeries. Surgical sealants are made from synthetic or natural polymers or a combination of both. Sealant materials are required to be elastic and compliant with the tissue to allow movement and function of various tissues of lungs, blood vessel, skin, and heart.

These materials include polyurethane, glycol, and polyethylene glycol or naturally occurring polysaccharides or proteins. Polyurethane is used in biomedical sealants due to its property of strong adhesion and high elasticity to tissues. Polyethylene glycol in sealants is widely used as hemostatic adhesive and fluid barrier.

Synthetic biomedical sealants have higher mechanical strength and tissue bonding properties as compared to natural biomedical sealants. These physical properties and adhesion strength are some key factors of implementing biomedical sealants to seal the wound area without causing any hindrance to the function and movement of tissues. Surgical sealants are used commonly to prevent leakage of any fluid or air from a surgical incision.

Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/1936

Biomedical Sealant Market Drivers:-

Approval of new biomedical sealants in key regions such as Europe is expected to drive growth of the biomedical sealant market. For instance, in 2017, Starch Medical, marketer and manufacturer of polysaccharide-based hemostatic products such as biomedical sealants was approved by C.E. Mark for Super Clot. Post the approval, company has planned to utilize their existing network of distribution partners along with their new strategic partners to bring Super Clot to hospitals and surgical teams throughout Europe. This strategic planning of product distribution is expected to fuel growth of the global biomedical sealant market.

Mergers and acquisitions by key players is also another factor expected to support the global biomedical sealant market growth. For instance, in January 2018, Baxter International Inc., a U.S.-based healthcare company, acquired two surgical products i.e. Recothrom and Preveleak of Mallinckrodt Pharmaceuticals—a producer of specialty pharmaceutical products. Recothrom is a thrombin based topical product, which is designed to assist hemostasis, this product is used when surgical methods to prevent flow of blood is ineffective in adults and pediatrics. Preveleak is a surgical sealant used to close suture holes to obtain hemostasis during surgical vascular reconstructions.

Ask for TOC : https://www.coherentmarketinsights.com/ongoing-insight/toc/1936

Biomedical Sealant Market Regional Analysis:-

North America is expected to be dominant in the global biomedical sealant market over the forecast period. This is due to increasing product launches by key players in the region. For instance, in 2017, Starch Medical, a marketer and manufacturer of polysaccharide-based hemostatic products such as biomedical sealants, launched its new product Super Clot. Super Clot is a biomedical sealant used for effective and rapid hemostasis. Such new products in the market are expected to boost growth of the North America biomedical sealant market.

Europe biomedical sealant market is also expected to exhibit significant growth over the forecast period. This is due to increasing number of approvals for new products by Certification Marking (C.E. Mark). For instance, in 2017, Gecko Medical, a medical device company which develops innovative polymers to support reconstruction of tissue, announced C.E mark approval for its product SETALUM sealant.

SETALUM sealant is bio-reabsorb able, biocompatible, and can also be used in dynamic and wet environments such as blood as an add-on to sutures during vascular surgeries. This sealant is applied to tissue in an appropriate position and is further activated using a light activation pen. This sealant is easily applicable due to its viscosity and hydrophobicity..

Biomedical Sealant Market Taxonomy:-

By Product Type:-

  • Solid
  • Liquid
  • Others

By Applications:-

  • Vascular surgery
  • Cardiovascular Surgery
  • Gynecology Surgery
  • Urology Surgery
  • Reconstructive and Plastic Surgery
  • Others

By End Users:-

  • Hospitals/clinics
  • Ambulatory Surgery Centers
  • Others

By Region:-

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East
  • Africa

Request for Discount Before Buying This Business Reports @ https://www.coherentmarketinsights.com/insight/request-discount/1936

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Gesundheit/Medizin

DAK-Gesundheit – Arzt-Hotline zum Schulstart in Karlsruhe

 Arzt-Hotline zum Schulstart in Karlsruhe

Experten der DAK-Gesundheit beraten rund um einen gesunden Start ins neue Schuljahr

 

Karlsruhe, 10.08.2018. Nach den großen Ferien starten alle Schüler in Baden-Württemberg in ein neues Schuljahr. Damit das erfolgreich und vor allem gesund verläuft, schaltet die DAK-Gesundheit Karlsruhe am 16. August eine Expertenhotline für Eltern schulpflichtiger Kinder. Dieses spezielle Serviceangebot unter der kostenlosen Rufnummer 0800 1111 841 können Kunden aller Krankenkassen nutzen.

 

Wie sieht der ideale Pausensnack aus? Wie erkenne ich, dass mein Kind überfordert ist, und wie sollten die Schulsachen gepackt sein, damit keine Rückenprobleme auftreten? Diese und viele anderen Fragen rund um einen gesunden Schulalltag beantworten die Ärzte an der Beratungshotline der DAK-Gesundheit.

 

Viele Schüler verzichten aufs Frühstück

Grundsätzlich sollten Kinder und Jugendliche während des Schultages genügend essen und trinken. Die Realität sieht aber oft anders aus. Die Folge sind Konzentrationsschwäche und Leistungsdurchhänger. „Wer morgens partout nichts runterkriegt, sollte zumindest ein Glas Saft oder Milch trinken“, rät Jana Eßbauer von der DAK-Gesundheit Karlsruhe. In der ersten Pause könne dann ausgiebig gefrühstückt werden. Im Idealfall Vollkornbrot mit Käse, dazu Obst oder Gemüse und ein zuckerarmes Getränk. Auch das Thema Schlaf ist zum Schulstart aktuell“, ergänzt Eßbauer „Nur Kinder, die gut schlafen, können auch gut lernen.“ Doch wie erkennen Eltern Schlafstörungen bei ihrem Kind? Und welche Schlafdauer ist die richtige? Diese und andere Fragen beantworten die Experten der DAK-Gesundheit am 16. August von 8 bis 20 Uhr. Ausführliche Infos zum Thema Schulranzen und gesunder Rücken gibt es auch im Internet unter: www.dak.de/ranzen

 

 

Gesundheit/Medizin Pressemitteilungen

Secondary Hyperparathyroidism Treatment Market Analysis 2026

Secondary hyperparathyroidism (SHPT) refers to one of the serious, common, and progressive complication associated with Chronic Kidney Disease (CKD) that is mainly characterized by high levels of parathyroid hormone, mineral metabolism abnormalities, and parathyroid gland hyperplasia. Failing kidneys are unable to convert Vitamin A to its active form as they do not adequately excrete phosphate resulting into formation of insoluble calcium phosphate by the body thus, leading to secondary hyperparathyroidism. The common signs and symptoms of the disease includes bone and joint pain as well as limb deformities. The disturbances caused in the secondary hyperparathyroidism patients may lead to poor quality of life and short life expectancy.

Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/1570

Rising prevalence of benign prostate hyperplasia in adults is expected to drive the growth of Secondary Hyperparathyroidism Treatment Market: Market Dynamics

Rising incidence of chronic kidney diseases is one of the major factors responsible for growth of the global secondary hyperparathyroidism treatment market. According to Centers of Disease Control & Prevention (CDC) 2017, 30 million people or 15% of the U.S. adults are estimated to have chronic kidney disease, out of which 48% suffer severely with reduced kidney function, however, are not aware of having a CKD. Moreover, according to the National Kidney Foundation 2016, 10% of the population across the world are affected with chronic kidney diseases. Additionally, extensive research in the field of nephrology to come up with new drugs and therapies for treatment of secondary hyperparathyroidism is responsible for fueling growth of the market. For instance, Sanofi SA’s Hectorol capsules is undergoing Phase 3 clinical trials to evaluate the safety and efficacy of this medication in reducing the level of secondary hyperparathyroidism in pediatric patients with chronic kidney diseases at stage 3 and 4. The drug is expected to complete its study in December 2017, and be commercially available in market. However, side effects usually associated with secondary hyperparathyroidism treatment such as muscle spasm, diarrhea, and vomiting may cause hindrance to growth of the market.

Ask for TOC : https://www.coherentmarketinsights.com/ongoing-insight/toc/1570

Secondary Hyperparathyroidism Treatment Market: Competitive Analysis

Key players operating in the global secondary hyperparathyroidism treatment market include AbbVie, Inc., Shire, Inc., OPKO Health, Amgen, Inc., Sanofi SA, F. Hoffmann-La Roche AG, Kyowa Hakko Kirin Co. Ltd., KAI Pharmaceuticals, Astellas Pharma, Inc., Deltanoid Pharmaceuticals, and Leo Pharma. Major players are focusing on innovation and new product development, to maintain their position in the market and enhance their share. For instance, in June 2016, OPKO Health introduced Rayaldee (calcifediol) for the treatment of SHPT in adults with stage 3 or 4 of chronic kidney disease.

Secondary Hyperparathyroidism Treatment Market: Market Taxonomy

The global secondary hyperparathyroidism treatment market by Coherent Market Insights is segmented on the basis of drug class and distribution channel.

On the basis of drug class, the global secondary hyperparathyroidism treatment market is segmented into:

  • Vitamin D Derivatives
    • Calcitriol
    • Doxercalciferol
    • Paracalcitol
  • Calcimimetics
  • Phosphate Binders
    • Calcium-Based Binders
    • Non-Calcium Based Binders

On the basis of distribution channel, the global secondary hyperparathyroidism treatment market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Request for Discount Before Buying This Business Reports @ https://www.coherentmarketinsights.com/insight/request-discount/1570

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Gesundheit/Medizin

Orthopedic Medical Imaging Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Worldwide Market Reports added Latest Research Report titled “ Orthopedic Medical Imaging Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 “ to its Large Report database.

Orthopedic medical imaging is visualization of musculoskeletal system, which includes bones, joints, ligaments, muscles, nerves, and tendons for clinical diagnosis, treatment anddisease monitoring. Imaging techniques encompassing the fields of radiology, nuclear medicineandoptical imaging and image-guided intervention. Bone disorders such as fractures, osteosarcoma, rickets, and osteoporosis can be diagnosed using orthopedic medical imaging.

High presence of bone disorders, owing Increasing number of geriatric population and increasing incidences of accidents are the major factors driving growthof the orthopedic medical imaging market. According toNational Center for Biotechnology Information (NCBI), Bone Health and Osteoporosis report, an estimated 1.5 million individuals suffer from fracture due to bone disease worldwide.

To get holisticSAMPLE of the report, please click: https://www.worldwidemarketreports.com/sample/156008

The risk of a fracture increases with age and is highest in women as compared to men. Increasing number of aging population is resultinginto highprevalence of osteoporosis and low bone mass. One in two Americans over age 50. However,high cost of medical imaging and mild side-effects such as skin rash, nausea, and headache are key factors restraining growth of the orthopedic medical imaging market.

Enquire here get customization & check discount, please click: https://www.worldwidemarketreports.com/discount/156008

Key Developments of Orthopedic Medical Imaging Market

Manufacturers are focusing on developing advanced techniques for medical imaging in real-time. For instance, in February 2018, Siemens Healthcare has received the US Food and Drug Administration (FDA) approval for GOKnee3D, a magnetic resonance imaging (MRI) application that significantly reduces the time it takes to complete diagnostic exams. GOKnee3D enables a push-button diagnostic 3-D knee exam in just 10 minutes – a substantial reduction from the standard MR knee examination. Acquisition of high-resolution isotropic 3-D images enables flexible evaluation of these images in all planes, including double oblique and curved plan. Furthermore, in 2018, FDA approved weight bearing 3D imaging technology, which allows radiologists to image patients in a standing or even simultaneous position. Advances in radiology and imaging techniquesis creating opportunity for market players to develop new medical imaging devices ofimaging instruments from medical sector. thisin turn is fueling growthof the orthopedic medical imaging market. The major players operating inorthopedic medical imaging markets include Hitachi, Toshiba Medical Systems, Carestream Health, Company E, GE Healthcare, and Siemens Healthcare.

To get detailed table of content (ToC): ToC): https://www.worldwidemarketreports.com/toc/156008

Key Reasons to Purchase:

  • To gain insightful analyzes of the market and have comprehensive Understanding the orthopedic medical imaging market and its commercial landscape.

  • Assess the Orthopedic Medical Imaging Market production processes, major issues, and solutions to mitigate the development risk.

  • To understand the most important driving and restraining forces in the Orthopedic Medical Imaging Market and its impact in the global market.in the global market.

  • Learn about the market strategies .

  • To understand the outlook and prospects for Orthopedic Medical Imaging Market.

In conclusion, Orthopedic Medical Imaging Market Report presents the descriptive analysis of the parent market based on elite players, present, past and futuristic data which aims to be a profitable guide to all orthopedic medical imaging market competitors.

** If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and exhaustive lists of sub-domains under the sun. The in-depth market analysis provides some of the most extensive analysts in the marketplace. Worldwide Market Research | Research and Development | Research and Development | Research and Development | Research and Development |

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

# 3200

Seattle, WA 98154, US

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Website:

Visit our new website: https://www.industrychronicle.com

Gesundheit/Medizin

Ambulatory Blood Pressure Monitors Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis

Worldwide Market Reports added Latest Research Report titled “ Ambulatory Blood Pressure Monitors Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis “ to its Large Report database.

The Global Ambulatory Blood Pressure Monitors Market was valued at $ 1,064.6 million in 2015 and is projected to expand at a CAGR of 8.0% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Prevalence of cardiovascular diseases attributed to blood pressure are expected to become major factors drivinggrowth of the global ambulatory blood pressure monitors over the foreseeable future.

Hypertension is driven by suboptimal behavioral factors such as excessive salt consumption, inadequate physical activity and the lack of adherence to antihypertensive medications are common in emerging economies. High blood pressure often has no observatory symptoms and if left untreated over time, can cause serious health conditions, such as heart disease and stroke. According to the American Stroke Association 2015, cardiovascular disorders are the leading cause of death for 17.3 million deaths per year, a figure that is expected to grow to more than 23.6 million by 2030.The rising hypertension related cardiovascular disorders are thereby, contributing to growth of global ambulatory blood pressure monitoring devices that are extremely useful to keep track of.

To get holisticSAMPLE of the report, please click: https://www.worldwidemarketreports.com/sample/187623

Obesity is largely linked to higher incidence rates of hypertension than normal-weight individuals. Excess weight gain associated with increased visceraladiposity,accounts for 65% to 75% of the risk for human primary hypertension. According to the World Health Organization 2016, approximately 1.9 billion adults were overweight. Of these, over 600 million people were obese. So, around 41 million children under the age of 5 years have been with 50% of total children living inasiaPacific. The key developments in the ambulatory blood pressure monitor devices offer pain-free andstress free 24-hour blood pressure check for efficient management and healthcare solutions with variable cuff sizes.

The highest risk of high blood pressure arethose who suffer from obesity, those suffering from diabetes, and those with chronic kidney disease. The requirement for self-health monitoring and preventive medicine is increasing due to the projected dramatic increase in the number of age-related disorders. According to the National Council of Aging 2017, approximately 92% of older adults have at least one chronic disease, increasing the reliability of ambulatory blood pressure monitor for periodic assessment, owing to its easy mechanism and enhanced accuracy. The US Preventive Services Task Force on Prevention of the Disruption of Diseases they can continuously monitor blood pressure fluctuations. Key players are developing wearable andeDeviceto enhance healthcare connectivity as an alternative for coping with the hectic life schedule of the people. For instance, the collaboration of iHealth Labs with Apple Inc. combines MyVital’s App with Apple’s Health Application integrating advanced health monitoring for the global iPhone users.

Enquire here get customization & check discount, please click: https://www.worldwidemarketreports.com/discount/187623

Key takeaways of the market:

The global ambulatory blood pressure monitors market is expected to expand to a CAGR of 8.0% during the forecast period (2017-2025) as well as Asia Pacific, Latin America, Middle East and Africa.

The wrist ambulatory blood pressure monitorsdominates The market in the product segment, as it is, is widely used with variable cuff sizes in medical healthcare facilities.

Home care settings and hospitals are the major end users of ambulatory blood pressure monitors market, as these devices offer accuracy with periodic measurements of blood pressure.

Some of the major players involved in global ambulatory blood pressure monitor markets are OSI Systems, SunTech Medical, Andon Health Co., Ltd., Schiller AG, Omron Healthcare, Beurer GmBH, Finapres Medical Systems, Welch Allyn, Inc. and

To get detailed table of content ( https://www.worldwidemarketreports.com/toc/187623

Key Reasons to Purchase:

  • To gain insightful analyzes of the market and have comprehensive the Ambulatory Blood Pressure Monitors Market and its Commercial Landscape .

  • Assess the Ambulatory Blood Pressure Monitors Market production processes, major issues, and solutions to mitigate the development risk.

  • To understand the most urgent driving and restraining forces in the Ambulatory Blood Pressure Monitors Market and its impact

  • Learn about the market strategies .

  • To understand the outlook and prospects for Ambulatory Blood Pressure Monitors Market.

** If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and exhaustive lists of sub-domains under the sun. The in-depth market analysis provides some of the most extensive analysts in the marketplace. Worldwide Market Research | Research and Development | Research and Development | Research and Development | Research and Development |

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

# 3200

Seattle, WA 98154,

US

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Website: https://www.worldwidemarketreports.com

Visit our new website: https://www.industrychronicle.com

Aktuelle Nachrichten Bücher/Zeitschriften Familie/Kinder Gesundheit/Medizin Pressemitteilungen Rat und Hilfe

Jutta Schütz bei bücher.de: Hilfe bei Schwangerschaftsdiabetes

Ein Schwangerschaftsdiabetes (Gestationsdiabetes) ist eine Form der Zuckerkrankheit. Sie wird auch Kohlenhydratstoffwechselstörung oder Glukose-Toleranzstörung genannt. Sie tritt meist in der 24. bis 28. Schwangerschaftswoche auf. Zum Beispiel können die Kinder sehr groß werden, was Komplikationen bei der Geburt verursachen kann.

 

Der hohe Zuckerspiegel in der Schwangerschaft gefährdet Mutter und Kind und für die Mutter steigt das Risiko für hohen Blutdruck. Daraus kann sich eine lebensbedrohliche Krankheit entwickeln, eine Pröeklampsie. Sie wird auch EPH-Gestose, Schwangerschaftsvergiftung, Spätgestose, Schwangerschaftsintoxikation oder Schwangerschaftstoxikose genannt.

Die schlimmste Ausprägung ist Eklampsie (Krampfanfall, HELLP-Syndrom). Hier bricht der ganze Organismus zusammen. Außerdem besteht ein erhöhtes Risiko einer Harnwegs- oder Scheidenentzündung. Dies kann zu vorzeitigen Wehen führen.

Zirka fünf Prozent der werdenden Mütter leiden in Deutschland unter Schwangerschaftsdiabetes.

Dieser Diabetes wird auch als Typ 4 Diabetes bezeichnet. Er verschwindet oft wieder nach der Schwangerschaft, aber während der Schwangerschaft ist diese Erkrankung nicht zu unterschätzen. Es besteht ein großes Risiko für Mutter und Kind.

Schwangere bemerken oft nichts von ihrer Erkrankung, da der Schwangerschaftsdiabetes meist beschwerdefrei bleibt. Grundsätzlich kann jede Schwangere an Schwangerschaftsdiabetes erkranken.

 

Buchempfehlung:

Hilfe bei Schwangerschaftsdiabetes

Infos, Tipps und Rezepte

Autorin: Jutta Schütz

Verlag: Books on Demand

ISBN-13: 9783752851007

Paperback

64 Seiten

Erscheinungsdatum: 03.05.2018

Sprache: Deutsch

erhältlich als:

BUCH 4,99 €  E-BOOK 3,99 €

https://www.buecher.de/shop/buecher/hilfe-bei-schwangerschaftsdiabetes/schuetz-jutta/products_products/detail/prod_id/52534379/

 

Diese Presse darf ausschließlich zu informativen, persönlichen und NICHT-kommerziellen Zwecken verwendet werden. Sie dürfen diese Presse ansehen, drucken, kopieren und weitergeben unter folgenden Bedingungen: Die Presse darf nur verwendet werden für den persönlichen, nicht kommerziellen Gebrauch. Die Presse muss bei einer Kopie oder bei einem Teilausschnitt alle rechtlichen Informationen wie das Originaldokument sowie auch das Copyright-Recht „© 2018 Jutta Schütz“ enthalten. Das Werk, einschließlich seiner Teile, ist urheberrechtlich geschützt.

 

Firmeninformation:

Jutta Schütz schreibt Bücher, die anspornen, motivieren und spezielles Insiderwissen liefern. Sie hat bis heute viele Bücher geschrieben und an vielen anderen Büchern mitgewirkt. Zudem hilft sie als Mentorin und Coach vielen Neuautoren bei der Veröffentlichung ihrer Bücher. Als Journalistin schreibt Schütz für viele Verlage und Zeitungen. Ihre Themen sind: Gesundheit, Psychologie, Kunst, Literatur, Musik, Film, Bühne, Entertainment. Weitere Informationen zur Autorin und ihren Büchern findet man in den Verlagen, auf ihrer Webseite – sowie im Kultur-Netzwerk.

 

Pressekontakt:

Jutta Schütz

Achenkamp 0

D-33611 Bielefeld

info.schuetz09@googlemail.com

www.jutta-schuetz-autorin.de/

www.die-gruppe-48.net

Aktuelle Nachrichten Bücher/Zeitschriften Gesundheit/Medizin Pressemitteilungen Rat und Hilfe Recht/Gesetz/Anwalt

Jutta Schütz bei bücher.de: Cannabis im medizinischen Einsatz

CANNABIS ist in unseren Breitengraden als Rauschmittel bekannt, dabei hat es medizinisch einen hohen Nutzen. Einige Substanzen in Haschisch und Marihuana haben erstaunliche medizinische Wirkungen. Aus diesen Gründen wird Hanf auch in der Medizin eingesetzt. Die Anwendung ist streng geregelt.

 

Zum Beispiel kann die Pflanze die Leiden chronischer Schmerzpatienten (z. B.: Diabetische Kardiomyopathie, Multiple Sklerose, Parkinson, Migräne) verringern und die Übelkeit und das Erbrechen von Krebspatienten lindern.

Ein Allheilmittel ist Cannabis nicht, es gibt heute aber sehr viele Anwendungsbereiche, wo Cannabis eine effektive und nebenwirkungsarme Medizin darstellt.

 

Buchempfehlung:

Cannabis im medizinischen Einsatz

Mehr als nur eine Droge

Autorin: Jutta Schütz

Verlag: Books on Demand

ISBN-13: 9783738632828

Paperback

Erscheinungsdatum: 10.08.2015

Sprache: Deutsch

erhältlich als:

BUCH 4,99 €  E-BOOK 4,49 €

https://www.buecher.de/shop/fachbuecher/cannabis-im-medizinischen-einsatz/schuetz-jutta/products_products/detail/prod_id/43536517/

 

Diese Presse darf ausschließlich zu informativen, persönlichen und NICHT-kommerziellen Zwecken verwendet werden. Sie dürfen diese Presse ansehen, drucken, kopieren und weitergeben unter folgenden Bedingungen: Die Presse darf nur verwendet werden für den persönlichen, nicht kommerziellen Gebrauch. Die Presse muss bei einer Kopie oder bei einem Teilausschnitt alle rechtlichen Informationen wie das Originaldokument sowie auch das Copyright-Recht „© 2018 Jutta Schütz“ enthalten. Das Werk, einschließlich seiner Teile, ist urheberrechtlich geschützt.

 

Firmeninformation:

Jutta Schütz schreibt Bücher, die anspornen, motivieren und spezielles Insiderwissen liefern. Sie hat bis heute viele Bücher geschrieben und an vielen anderen Büchern mitgewirkt. Zudem hilft sie als Mentorin und Coach vielen Neuautoren bei der Veröffentlichung ihrer Bücher. Als Journalistin schreibt Schütz für viele Verlage und Zeitungen. Ihre Themen sind: Gesundheit, Psychologie, Kunst, Literatur, Musik, Film, Bühne, Entertainment. Weitere Informationen zur Autorin und ihren Büchern findet man in den Verlagen, auf ihrer Webseite – sowie im Kultur-Netzwerk.

 

Pressekontakt:

Jutta Schütz

Achenkamp 0

D-33611 Bielefeld

info.schuetz09@googlemail.com

www.jutta-schuetz-autorin.de/

www.die-gruppe-48.net

Aktuelle Nachrichten Bücher/Zeitschriften Familie/Kinder Gesundheit/Medizin Pressemitteilungen Rat und Hilfe

Jutta Schütz bei bücher.de: Kinderwunsch mit Multiple Sklerose

Männer und Frauen mit Multiple Sklerose (MS) können genauso Eltern werden wie gesunde, und Frauen mit MS bekommen genauso häufig ein gesundes Kind wie Frauen ohne MS.

 

Die Krankheit „Multiple-Sklerose“ alleine ist jedenfalls kein Grund, auf Kinder verzichten zu müssen. Bei Männern mit MS führt die Krankheit NICHT zur Zeugungsunfähigkeit, sie haben aber zeitweise Erektionsstörungen, die sich jedoch gut behandeln lassen. Wenn Neurologe und Gynäkologe in den Phasen von Familienplanung, Schwangerschaft sowie Geburt gut zusammenarbeiten, können sie die Frauen gut begleiten. Multiple Sklerose ist keine Erbkrankheit – sie hat jedoch genetische Faktoren. Studien belegen: Das relative Risiko, an Multipler Sklerose zu erkranken, ist bei Kindern eines MS-Erkrankten Elternteils „im Vergleich zur regionalen Bevölkerung“ nur geringfügig erhöht.

 

Buchempfehlung:

Kinderwunsch mit Multiple Sklerose

Von der Planung der Schwangerschaft bis nach der Geburt

Autorin: Jutta Schütz

Verlag: Books on Demand

ISBN-13: 9783741273209

Paperback

156 Seiten

Erscheinungsdatum: 28.09.2016

Sprache: Deutsch

erhältlich als:

BUCH 7,99 €  E-BOOK 5,99 €

https://www.buecher.de/shop/gesundheit–medizin/kinderwunsch-mit-multiple-sklerose/schuetz-jutta/products_products/detail/prod_id/46003739/

 

Diese Presse darf ausschließlich zu informativen, persönlichen und NICHT-kommerziellen Zwecken verwendet werden. Sie dürfen diese Presse ansehen, drucken, kopieren und weitergeben unter folgenden Bedingungen: Die Presse darf nur verwendet werden für den persönlichen, nicht kommerziellen Gebrauch. Die Presse muss bei einer Kopie oder bei einem Teilausschnitt alle rechtlichen Informationen wie das Originaldokument sowie auch das Copyright-Recht „© 2018 Jutta Schütz“ enthalten. Das Werk, einschließlich seiner Teile, ist urheberrechtlich geschützt.

 

Firmeninformation:

Jutta Schütz schreibt Bücher, die anspornen, motivieren und spezielles Insiderwissen liefern. Sie hat bis heute viele Bücher geschrieben und an vielen anderen Büchern mitgewirkt. Zudem hilft sie als Mentorin und Coach vielen Neuautoren bei der Veröffentlichung ihrer Bücher. Als Journalistin schreibt Schütz für viele Verlage und Zeitungen. Ihre Themen sind: Gesundheit, Psychologie, Kunst, Literatur, Musik, Film, Bühne, Entertainment. Weitere Informationen zur Autorin und ihren Büchern findet man in den Verlagen, auf ihrer Webseite – sowie im Kultur-Netzwerk.

 

Pressekontakt:

Jutta Schütz

Achenkamp 0

D-33611 Bielefeld

info.schuetz09@googlemail.com

www.jutta-schuetz-autorin.de/

www.die-gruppe-48.net